PulmoBioMed

PulmoBioMed is a startup based in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

PulmoBioMed develops a non-invasive breath sampling device called PBM-Hale™, which collects deep lung samples without contamination from the mouth or environment. This technology enables faster, safer, and more accessible lung disease diagnosis, addressing the limitations of existing invasive methods.